MBAI) Shares Up 10% on High Vol After CEO Appointment The AI Health-tech investing firm MedBright AI (Trading as MBAI.c or MBAIF for US investors) closed up 10% on over 3x its average volume after it announced today that it has appointed Trevor Vieweg as its new Chief Executive Officer.
MBAI, a dynamic capital allocator with a strategic focus on technology and healthcare investments, continues to make significant strides in its pursuit of high-quality opportunities.
Today, MBAI welcomed Trevor Vieweg as its new Chief Executive Officer. A seasoned professional, Mr. Vieweg brings a wealth of experience from his tenure as the Head of Product Development at Viasat (NASDAQ:VSAT) and later as the Chief Technology Officer of Sea Machines Robotics, a venture-backed AI and robotics start-up.
His credentials also include being an investor in and co-founder of Limmi, an artificial intelligence platform focused on powering complex healthcare data analytics systems—a strategic investment by MedBright AI.
Holding a Master’s degree in enterprise software architecture from the University of California, San Diego, Mr. Vieweg stands as a testament to MedBright AI's commitment to leadership excellence.
MBAI also announced its investor relations agreement with Outside the Box Capital Inc, which will provide investor relations and communication services to MBAI, leveraging social media platforms such as Twitter and YouTube.
Full news here: https://www.globenewswire.com/news-release/2024/01/04/2803971/0/en/MedBright-AI-Appoints-Trevor-Vieweg-as-Chief-Executive-Officer.html
Posted on behalf of Medbright AI Investments Inc.